
Oxford Cannabinoid Technologies Investor Relations Material
Latest events

H2 2024
24 Nov, 2024

H1 2023
29 Jan, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Oxford Cannabinoid Technologies Holdings PLC
Access all reports
Oxford Cannabinoid Technologies Holdings PLC is a UK-based pharmaceutical company focused on developing prescription cannabinoid-based therapies. The company targets conditions including chronic pain and neurological disorders, advancing its drug candidates through preclinical and clinical development phases. It operates within a regulated scientific framework and collaborates with academic partners. The company is headquartered in London, United Kingdom, and its shares are listed on the LSE.
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
OCTH
Country
🇬🇧 United Kingdom